Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

NCT00331526 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: therapeutic autologous lymphocytes
PROCEDURE: adjuvant therapy
PROCEDURE: conventional surgery

Sponsor

Hoag Memorial Hospital Presbyterian